June 7, 2021 -- TransCelerate BioPharma subsidiary BioCelerate is launching an initiative to improve nonclinical research in partnership with the Center for Drug Evaluation and Research Office of Computational Science, a unit of the U.S. Food and Drug Administration (FDA).
BioCelerate will work with the FDA through the agency's Public Private Partnership program, which in part is working to streamline the sharing of nonclinical data through the Clinical Data Interchange Standards Consortium (CDISC) Standard for Exchange of Nonclinical Data (SEND), it said.
BioCelerate and the FDA have released two publications on the topic, one of which describes the SEND datasets and another of which describes how to create a database using SEND information.
Copyright © 2021 scienceboard.net